
Advanced Diploma in AI Applied to Oncology
Madrid, Spain
DURATION
20 Weeks
LANGUAGES
Spanish
PACE
Part time
APPLICATION DEADLINE
22 May 2025
EARLIEST START DATE
26 May 2025
TUITION FEES
EUR 1,840 *
STUDY FORMAT
Distance Learning
* Discounts for CEB alumni
Introduction
Why specialize in Artificial Intelligence?
Over the next three years, the industry will need more than 90,000 professionals with expertise in data and artificial intelligence.
AI is a necessary tool in the oncology field for molecular diagnosis, image analysis and early detection, risk prediction by stratifying patients, planning personalized treatments, drug development against specific targets, patient follow-up and monitoring, and for clinical and administrative support.
Why study AI applied to Oncology?
Studying an advanced diploma in Artificial Intelligence (AI) and seeing its application in oncology will allow you to:
Revolution in diagnosis and treatment Revolution in early detection of cancer
Artificial intelligence is transforming oncology by improving the accuracy of early tumor detection, both through advanced analysis of medical images such as mammograms, ultrasounds, CT scans and MRIs, and through the accurate identification and interpretation of biomarkers. Thanks to AI, it is possible to identify subtle patterns that might otherwise go unnoticed by the human eye, significantly increasing early detection rates.
Optimizing biomedical research Personalization of oncological treatments
AI makes it possible to analyse large volumes of clinical, genetic and molecular data to design personalised treatments, adapted to the genetic and molecular profile of each patient. This helps to optimise therapies, reducing side effects and improving the efficacy of the treatment and, therefore, life expectancy and quality of life.
Optimizing clinical decision making
AI algorithms facilitate the interpretation of complex oncology data, providing healthcare professionals with evidence-based decision support tools. This translates into more accurate diagnoses that allow molecular subclassification of tumors, more effective treatment plans based on personalized medicine, and better management of resources and time.
Accelerating oncology research
Artificial intelligence makes it possible to analyse and correlate large biomedical databases and biobanks, accelerating the discovery of new biomarkers and the development of new therapeutic strategies. In addition, AI contributes to the identification of patterns in clinical trial data, helping to predict responses with greater accuracy.
A field with high demand and professional projection
The combination of AI and oncology is booming, generating a high demand for professionals capable of integrating these technologies into clinical practice and research. Training in this field offers a competitive advantage in the job market and the opportunity to contribute to improving cancer care globally.
Our Experts
Our AI and oncology experts are internationally renowned professionals in the clinical and research fields of oncology. They work in prestigious institutions, combining their experience in oncology and artificial intelligence to offer you learning based on real cases and practical applications.